Kathryn C. Zoon - May 25, 2021 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
May 25, 2021
Transactions value $
-$177,291
Form type
4
Date filed
5/27/2021, 04:37 PM
Previous filing
May 24, 2021
Next filing
May 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$177K -3.14K -17.92% $56.48* 14.4K May 25, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
F2 All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
F3 The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86.